SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950135-07-002821
Filing Date
2007-05-04
Accepted
2007-05-04 12:29:26
Documents
2
Group Members
PETER KOLCHINSKYR.A. CAPITAL BIOTECH FUND, L.P.RICHARD H. ALDRICH

Document Format Files

Seq Description Document Type Size
1 RA CAPITAL MANAGEMENT SC 13G b65357rasc13g.htm SC 13G 80139
2 EX-99.(A) AGREEMENT REGARDING JOINT FILING b65357raexv99wxay.htm EX-99.(A) 9710
  Complete submission text file 0000950135-07-002821.txt   91864
Mailing Address 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022 212-716-1810
Innovive Pharmaceuticals, Inc. (Subject) CIK: 0001337223 (see all company filings)

IRS No.: 743123261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81908 | Film No.: 07819009
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199
Business Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199 617-778-2512
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G